Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes. 1978

E K Manesis, and C H Cameron, and G Gregoriadis

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E K Manesis, and C H Cameron, and G Gregoriadis
April 1984, Liver,
E K Manesis, and C H Cameron, and G Gregoriadis
January 1978, Vox sanguinis,
E K Manesis, and C H Cameron, and G Gregoriadis
January 1979, Digestion,
E K Manesis, and C H Cameron, and G Gregoriadis
October 1988, Journal of postgraduate medicine,
E K Manesis, and C H Cameron, and G Gregoriadis
January 1983, Leprosy in India,
E K Manesis, and C H Cameron, and G Gregoriadis
August 1989, Chinese medical journal,
E K Manesis, and C H Cameron, and G Gregoriadis
July 1978, Annales de microbiologie,
E K Manesis, and C H Cameron, and G Gregoriadis
January 1978, Acta haematologica Polonica,
E K Manesis, and C H Cameron, and G Gregoriadis
February 1981, Seminars in liver disease,
E K Manesis, and C H Cameron, and G Gregoriadis
September 2003, Virology,
Copied contents to your clipboard!